Khan Najat

Recursion Pharmaceuticals, Inc. · CEO and President

Khan Najat is listed in public filings as director, officer: CEO and President. This Khan Najat insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Recursion Pharmaceuticals, Inc. (RXRX). Investors use Khan Najat's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Recursion Pharmaceuticals, Inc.RXRX$7.8M2.2M sharesSellJun 5, 2026$84.5K23.6k shares$3.58--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Recursion Pharmaceuticals, Inc.RXRX$6.7M2.2M sharesGrant / ExerciseMay 15, 2026$190.6K62.7k shares$3.04--
Recursion Pharmaceuticals, Inc.RXRX$7.6M2.3M sharesSellMar 9, 2026$94.7K28.3k shares$3.35--
Recursion Pharmaceuticals, Inc.RXRX$8.0M2.3M sharesGrant / ExerciseFeb 17, 2026$49.8K14.3k shares$3.49--
Recursion Pharmaceuticals, Inc.RXRX--2.3M sharesGrant / ExerciseFeb 6, 2026Disclosure amount unavailable1.7M shares----
Recursion Pharmaceuticals, Inc.RXRX--2.3M sharesGrant / ExerciseFeb 6, 2026Disclosure amount unavailable30.3k shares----
Recursion Pharmaceuticals, Inc.RXRX$9.2M2.3M sharesGrant / ExerciseFeb 6, 2026$41.2K10.4k shares$3.98--
Recursion Pharmaceuticals, Inc.RXRX$2.7M611.1k sharesSellDec 22, 2025$548.6K124.4k shares$4.41--
Recursion Pharmaceuticals, Inc.RXRX$3.0M735.5k sharesGrant / ExerciseNov 17, 2025$72.8K17.6k shares$4.14--
Recursion Pharmaceuticals, Inc.RXRX$842k169.9k sharesGrant / ExerciseNov 5, 2025$842.5K169.9k shares$4.96--
Recursion Pharmaceuticals, Inc.RXRX--753.1k sharesGrant / ExerciseNov 5, 2025Disclosure amount unavailable84.9k shares----
Recursion Pharmaceuticals, Inc.RXRX$3.7M668.2k sharesSellAug 18, 2025$202.2K36.6k shares$5.52--
Recursion Pharmaceuticals, Inc.RXRX$4.0M704.8k sharesGrant / ExerciseAug 15, 2025$21.4K3.8k shares$5.64--
Recursion Pharmaceuticals, Inc.RXRX$3.0M708.6k sharesGrant / ExerciseMay 15, 2025$16.1K3.8k shares$4.25--
Recursion Pharmaceuticals, Inc.RXRX$3.0M420.2k sharesGrant / ExerciseFeb 3, 2025$3.0M420.2k shares$7.25--
Recursion Pharmaceuticals, Inc.RXRX--707.1k sharesGrant / ExerciseFeb 3, 2025Disclosure amount unavailable210.1k shares----
Recursion Pharmaceuticals, Inc.RXRX--715.1k sharesGrant / ExerciseFeb 3, 2025Disclosure amount unavailable8k shares----
Recursion Pharmaceuticals, Inc.RXRX$5.2M712.4k sharesGrant / ExerciseFeb 3, 2025$20.0K2.8k shares$7.25--